Cargando…
ZDHHC2-Mediated AGK Palmitoylation Activates AKT–mTOR Signaling to Reduce Sunitinib Sensitivity in Renal Cell Carcinoma
Tyrosine kinase inhibitors (TKI) that can suppress the VEGF signaling pathway and angiogenesis have been developed to impede the progression of malignant tumors and have been approved as first-line targeted agents for clear cell renal cell carcinoma (ccRCC). Dysregulation of lipid metabolism is a ma...
Autores principales: | Sun, Yan, Zhu, Liang, Liu, Pian, Zhang, Huan, Guo, Feng, Jin, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267682/ https://www.ncbi.nlm.nih.gov/pubmed/37078777 http://dx.doi.org/10.1158/0008-5472.CAN-22-3105 |
Ejemplares similares
-
ZDHHC22-mediated mTOR palmitoylation restrains breast cancer growth and endocrine therapy resistance
por: Huang, Jiefeng, et al.
Publicado: (2022) -
Identification and dynamics of the human ZDHHC16-ZDHHC6 palmitoylation cascade
por: Abrami, Laurence, et al.
Publicado: (2017) -
Fatty Acid Oxidation Mediated by Malonyl-CoA Decarboxylase Represses Renal Cell Carcinoma Progression
por: Zhou, Lijie, et al.
Publicado: (2023) -
Palmitoylation controls the stability of 190 kDa ankyrin-G in dendritic spines and is regulated by ZDHHC8 and lithium
por: Piguel, Nicolas H., et al.
Publicado: (2023) -
ZDHHC7-Mediated S-Palmitoylation of Scribble Regulates Cell Polarity
por: Chen, Baoen, et al.
Publicado: (2016)